The Innovation Blueprint

Episode 44 Heart Failure Treatment Breakthroughs: A Conversation with Ayla Annac

33 min · 5 de jul de 2026
Portada del episodio Episode 44
Heart Failure Treatment Breakthroughs: A Conversation with Ayla Annac

Descripción

Heart failure is still one of the world’s leading causes of death, yet investment and innovation continue to lag behind cancer research. Ayla Annac explains why large-scale cardiac trials keep failing, how AI could radically improve patient targeting, and why the future of precision medicine depends on collaboration between pharma, hospitals, software teams, and regulators. From clinical trial design to patient data ethics, the conversation explores what it will take to finally modernize cardiac drug development.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de The Innovation Blueprint!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

44 episodios